<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>Jianpi Huayu Decoction enhances the effect of sorafenib and alleviates adverse events in hepatocellular carcinoma by remodeling the gut microbiota</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Xue</namePart>
      <namePart type="family">Deng</namePart>
      <displayForm>Deng, Xue</displayForm>
      <affiliation>School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China</affiliation>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Yingjie</namePart>
      <namePart type="family">Xie</namePart>
      <displayForm>Xie, Yingjie</displayForm>
      <affiliation>General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Yantong</namePart>
      <namePart type="family">Lu</namePart>
      <displayForm>Lu, Yantong</displayForm>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <affiliation>Guangzhou University of Chinese Medicine, Guangzhou, 510006, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Xueyan</namePart>
      <namePart type="family">Li</namePart>
      <displayForm>Li, Xueyan</displayForm>
      <affiliation>School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China</affiliation>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Xuan</namePart>
      <namePart type="family">Guo</namePart>
      <displayForm>Guo, Xuan</displayForm>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <affiliation>School of Medicine, South China University of Technology, Guangzhou, 510641, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Xuhui</namePart>
      <namePart type="family">Huang</namePart>
      <displayForm>Huang, Xuhui</displayForm>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Xiaohe</namePart>
      <namePart type="family">Lan</namePart>
      <displayForm>Lan, Xiaohe</displayForm>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Juze</namePart>
      <namePart type="family">Lin</namePart>
      <displayForm>Lin, Juze</displayForm>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Wei</namePart>
      <namePart type="family">Tan</namePart>
      <displayForm>Tan, Wei</displayForm>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Changjun</namePart>
      <namePart type="family">Wang</namePart>
      <displayForm>Wang, Changjun</displayForm>
      <affiliation>School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China</affiliation>
      <affiliation>Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, 510508, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2022-03</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>There is an urgent need for effective treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multi-kinase inhibitor, is the first-line treatment for advanced HCC, which has a modest efficacy due to severe adverse effects (AEs), acquired resistance, and others. Jianpi Huayu Decoction (JHD) is a traditional Chinese medicine formulation, effective as an alternative and complementary therapy of HCC. Combined sorafenib with JHD is a potential approach to overcome sorafenib resistance. Effect and AEs of clinical-dose sorafenib combined JHD were evaluated in a subcutaneous model. Diarrhea, the most frequently reported AEs, was evaluated by diarrhea score. Illumina NovaSeq analyzed the gut microbiota (GM) composition of the mice. JHD administration enhanced anti-tumor response to sorafenib and prevented the occurrence of sorafenib-induced diarrhea and body weight loss. Proinflammatory GM Helicobacter positively correlated with sorafenib treatment while anti-inflammatory GM, Muribaculum, Fusicatenibacter, and Dorea positively correlated with JHD treatment. In addition, JHD decreased the infiltration of inflammatory cells and downregulated signaling of interleukin 6/signal transducer and activator of the transcription-3 pathway. Our finding suggested that JHD with microbiota modulation properties could significantly potentiate sorafenib and provide a promising treatment for advanced HCC. </abstract>
   <subject>
      <topic>Hepatocellular carcinoma</topic>
   </subject>
   <subject>
      <topic>Jianpi Huayu</topic>
   </subject>
   <subject>
      <topic>Decoction</topic>
   </subject>
   <subject>
      <topic>Sorafenib</topic>
   </subject>
   <subject>
      <topic>Microbiota</topic>
   </subject>
   <subject>
      <topic>AE</topic>
   </subject>
   <subject>
      <topic>GM</topic>
   </subject>
   <subject>
      <topic>HCC</topic>
   </subject>
   <subject>
      <topic>H&amp;E</topic>
   </subject>
   <subject>
      <topic>HPLC</topic>
   </subject>
   <subject>
      <topic>JAK2</topic>
   </subject>
   <subject>
      <topic>JHD</topic>
   </subject>
   <subject>
      <topic>LPS</topic>
   </subject>
   <subject>
      <topic>IHC</topic>
   </subject>
   <subject>
      <topic>IF</topic>
   </subject>
   <subject>
      <topic>MVD</topic>
   </subject>
   <subject>
      <topic>PCNA</topic>
   </subject>
   <subject>
      <topic>STAT3</topic>
   </subject>
   <subject>
      <topic>TCM</topic>
   </subject>
   <subject>
      <topic>VEGF</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Pharmacological Research - Modern Chinese Medicine</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier B.V.</publisher>
      </originInfo>
      <identifier type="issn">2667-1425</identifier>
      <part>
         <detail type="volume">
            <number>2</number>
            <caption>v.</caption>
         </detail>
         <text type="display-date">March 2022</text>
         <text type="year">2022</text>
         <text type="month">March</text>
         <extent unit="pages">
            <start>100057</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.prmcm.2022.100057</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.prmcm.2022.100057</url>
   </location>
   <identifier type="pii">S2667-1425(22)00018-5</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY-NC-ND 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2022-01-25"/>
         <licence_ref>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/576450669703096969-00001/2667-1425/S2667142521X00036/S2667142522000185/S2667142522000185.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
